Based in New York City, Weill Cornell Medicine Enterprise Innovation engages and collaborates with Weill Cornell Medicine faculty and trainees while fostering alliances with leaders in the biomedical industry and business and investment community. Our focus is to translate the application of emerging science and new technologies into world-class medical breakthroughs.
Integrating Weill Cornell Medicine’s Office of BioPharma Alliances and Research Collaborations, Center for Technology Licensing (CTL) at Weill Cornell, BioVenture eLab and Daedalus Fund for Innovation under a single, united organization, Enterprise Innovation encompasses the entire spectrum of an effective innovation ecosystem. We offer unique opportunities for faculty and trainees to transform their research into medical advances through collaborations including access to the Tri-Institutional Therapeutics Discovery Institute.
Dr. Behzad Aghazadeh’s professional ambition carried him to different continents, scientific disciplines and career focuses. But the one constant for the Weill Cornell Medicine alumnus has been a commitment to entrepreneurship.
In recognition of Cervical Health Awareness Month, Enterprise Innovation spoke with radiation oncologist Dr. Onyinye Balogun about her efforts to improve women's health technology. Dr. Balogun shared how an encounter with a cervical cancer patient inspired her to become an entrepreneur.